SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062039
Filing Date
2023-11-09
Accepted
2023-11-09 16:10:11
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxst-20231109.htm   iXBRL 8-K 48254
2 EX-99.1 rxst-ex99_1.htm EX-99.1 400256
3 GRAPHIC img261313502_0.jpg GRAPHIC 2587
  Complete submission text file 0000950170-23-062039.txt   586629

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxst-20231109_pre.xml EX-101.PRE 9830
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxst-20231109.xsd EX-101.SCH 2454
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxst-20231109_lab.xml EX-101.LAB 13350
8 EXTRACTED XBRL INSTANCE DOCUMENT rxst-20231109_htm.xml XML 4688
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

IRS No.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40690 | Film No.: 231392454
SIC: 3851 Ophthalmic Goods